Joseph R. Pare

Joseph R. Pare

Auto-generated profile, based on publicly available information

Joseph R. Pare

Department of Emergency Medicine, Boston University School of Medicine, Boston Medical Center, BCD Building, 800 Harrison Ave., Boston, MA 02118, United States of America

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2015 in Academic Emergency Medicine
Verified
Journal Article
Closed access
PDF file
MHM Kennedy Hall
M Kennedy Hall
ECE C Coffey
E C Coffey
MHMeghan Herbst
Meghan Herbst
RLRachel Liu
Rachel Liu
JPJoseph R Pare
Joseph R Pare
CMChris L Moore
Chris L Moore

1 March 2016 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
JPJoseph R. Pare
Joseph R. Pare
RLRachel Liu
Rachel Liu
CMChristopher L. Moore
Christopher L. Moore
TSTyler Sherban
Tyler Sherban
MKMichael S. Kelleher
Michael S. Kelleher
RTR. Andrew Taylor
R. Andrew Taylor

19 June 2020 in Western Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
JPJoseph R. Pare
Joseph R. Pare
ICIngrid Camelo
Ingrid Camelo
KMKelly C. Mayo
Kelly C. Mayo
MLMegan M. Leo
Megan M. Leo
JDJulianne N. Dugas
Julianne N. Dugas
ESElissa M. Schechter-Perkins
Elissa M. Schechter-Perkins
Introduction: Current recommendations for diagnostic imaging for moderately to severely ill patients with suspected coronavirus disease 2019 (COVID-19) include chest radiograph (CXR). Our primary objective was to determine whether lung ultrasound (LUS) B-lines, when excluding patients with alternative etiologies for B-lines, are more sensitive for the associated diagnosis of COVID-19 than CXR.Methods: This was a retrospective cohort study of all patients who presented to a single, academic emergency department in the United States between March 20 and April 6, 2020, and received LUS, CXR, and viral testing for COVID-19 as part of their diagnostic evaluation. The primary objective was to estimate the test characteristics of both LUS B-lines and CXR for the associated diagnosis of COVID-19. Our secondary objective was to evaluate the proportion of patients with COVID-19 that have secondary LUS findings of pleural abnormalities and subpleural consolidations.Results: We identified 43 patients who underwent both LUS and CXR and were tested for COVID-19. Of these, 27/43 (63%) tested positive. LUS was more sensitive (88.9%, 95% confidence interval (CI), 71.1-97.0) for the associated diagnosis of COVID-19 than CXR (51.9%, 95% CI, 34.0-69.3; p = 0.013). LUS and CXR specificity were 56.3% (95% CI, 33.2-76.9) and 75.0% (95% CI, 50.0-90.3), respectively (p = 0.453). Secondary LUS findings of patients with COVID-19 demonstrated 21/27 (77.8%) had pleural abnormalities and 10/27 (37%) had subpleural consolidations.Conclusion: Among patients who underwent LUS and CXR, LUS was found to have a higher sensitivity than CXR for the evaluation of COVID-19. This data could have important implications as an aid in the diagnostic evaluation of COVID-19, particularly where viral testing is not available or restricted. If generalizable, future directions would include defining how to incorporate LUS into clinical management and its role in screening lower-risk populations.

1 August 2012 in Emergency Medicine Clinics of North America
Verified
Journal Article
Closed access
JPJoseph R. Pare
Joseph R. Pare
JKJoseph H. Kahn
Joseph H. Kahn

1 June 2018 in Journal of Patient Safety
Verified
Journal Article
Closed access
PDF file
JPJoseph R. Pare
Joseph R. Pare
CMChristopher L. Moore
Christopher L. Moore
Objective: To determine characteristics of patients who develop compartment syndrome (CS) from IV infiltration requiring surgical intervention. Methods: A systematic review was conducted of available English literature from 1990 to date. Key terms were entered into a MEDLINE search in addition to searching grey literature and references of included manuscripts. Inclusion criteria were cases of CS requiring surgical intervention from IV infiltration. Exclusions were cases associated with phenytoin because of the unclear mechanism leading to injury (purple glove syndrome). Cases were reviewed for demographics, clinical information, and outcomes. Results: Literature search resulted in 32 manuscripts meeting inclusion with 51 cases. Age ranged from 3 days to 81 years (19.6% age 18 years [30/51]). IV sites were reported in 43 cases: hand 46.5%, forearm 46.5%, foot 4.7%, and leg 2.3% ([20/43], [20/43], [2/43], [1/43]). Of the 42 cases reporting patient mental status, 76.2% (32/42) had impaired mental state or limited communication including young age defined as younger than 3 years. Common associated agents were contrast 36.2%, IV fluid 34%, and mannitol 8.5% ([18/47], [16/47], [4/47]). One patient required hand amputation, 5 had persistent deficits, 36 had no long-term deficits, and 9 cases did not report patient outcomes. Conclusion: Compartment syndrome affects patients of all ages with a significant number of patients being pediatric and specifically younger than 1 year. Patients at highest risk of developing CS requiring surgery from IV infiltration are likely to have barriers to communication.

1 February 2019 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
JPJoseph R. Pare
Joseph R. Pare
SPSamara E. Pollock
Samara E. Pollock
JLJames H. Liu
James H. Liu
MLMegan M. Leo
Megan M. Leo
KNKerrie P. Nelson
Kerrie P. Nelson